ONTX - Onconova Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts3144
Avg. Estimate-0.25-0.21-2.07-2
Low Estimate-0.6-0.21-3.66-4.48
High Estimate-0.05-0.21-0.56-0.14
Year Ago EPS-1.37-1.29-4.99-2.07
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts3144
Avg. Estimate280k290k2.22M7.39M
Low Estimate60k290k2.2M1.14M
High Estimate700k290k2.25M18.3M
Year Ago Sales59k80k1.23M2.22M
Sales Growth (year/est)374.60%262.50%80.80%232.90%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.87-1.03-0.82-0.56
EPS Actual-1.37-1.29-0.6-0.75
Difference-0.5-0.260.22-0.19
Surprise %-57.50%-25.20%26.80%-33.90%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.25-0.21-2.07-2
7 Days Ago-0.48-0.21-2.76-2.53
30 Days Ago-0.48-0.21-2.76-2.53
60 Days Ago-0.48-0.21-2.76-2.53
90 Days Ago-0.54-0.45-2.76-2.25
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/A11
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesONTXIndustrySectorS&P 500
Current Qtr.81.80%N/AN/A0.01
Next Qtr.83.70%N/AN/A0.06
Current Year58.50%N/AN/A-0.02
Next Year3.40%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A